# Eledon Pharmaceuticals, Inc.: Form 8-K, filed Apr 2, 2018

- Company: [Eledon Pharmaceuticals, Inc.](/companies/eldn.md) (CIK 1404281)
- Form: 8-K
- Filed: 2018-04-02
- Accepted by EDGAR: Mar 30, 2018, 21:54 ET
- Period: 2018-03-30
- Accession: 0001564590-18-007316
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1404281/000156459018007316/nvus-8k_20180330.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1404281/000156459018007316/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1404281/000156459018007316/nvus-8k_20180330.htm

Filed Apr 2, 2018.
Source: SEC EDGAR, the filing index for accession 0001564590-18-007316. Last ingested by Listed: Nov 13, 2026, 16:16 ET. No prices; not investment advice.
